Subscribe
ken-wolter-shutterstock-com-2-
Ken Wolter / Shutterstock.com
28 July 2015Americas

Medtronic asks US Supreme Court to vacate infringement ruling

Medical device manufacturer Medtronic has asked the US Supreme Court to vacate a lower court ruling that it indirectly infringed a patent covering a machine used during spinal surgery, citing the latest ruling in Commil USA v Cisco Systems.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
US Supreme Court grants Medtronic’s GVR petition
20 January 2016   The US Supreme Court has ordered a re-hearing of a spinal surgery patent dispute after it granted Medtronic’s grant, vacate, and remand (GVR) petition in its row with NuVasive.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Americas
US Supreme Court grants Medtronic’s GVR petition
20 January 2016   The US Supreme Court has ordered a re-hearing of a spinal surgery patent dispute after it granted Medtronic’s grant, vacate, and remand (GVR) petition in its row with NuVasive.

More on this story

Americas
US Supreme Court grants Medtronic’s GVR petition
20 January 2016   The US Supreme Court has ordered a re-hearing of a spinal surgery patent dispute after it granted Medtronic’s grant, vacate, and remand (GVR) petition in its row with NuVasive.

More features

Gene tech firm fends off injunction in test kit dispute
Comparing life sciences IP in Brazil and the US
Gilead awarded $30m over counterfeit HIV drug scheme
EPO invalidates human milk patent after Nestle opposition
Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal